RETROVIR
NDC 49702-212, zidovudine, solution, from ViiV Healthcare Company.
- Product NDC
- 49702-212
- Status
- Listed
- Labeler
- ViiV Healthcare Company
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA019910
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49702-212 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZIDOVUDINE10 mg/mL
Pharmacologic classes
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49702-212-48 | 49702021248 | 240 mL in 1 BOTTLE (49702-212-48) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6df09f15-b102-431c-adde-d7aeef6f5d84
Use it
Look up 49702-212 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49702-212 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49702-212. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.